GSS Shares Genetic Signatures Limited
ASX · ASXLast in our picks 2026-10-07 — not in the current list; analysis below is from that screen
Commodity-linked microcap with minimal semiconductor relevance and weak investability.
Future value: $0.31 (+292.41%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Category fit is poor and catalysts are limited.
- ▸Above 50-day MA (+8.67%)
- ▾Near 52-week low (7.4% of range)
- ▸~292% upside to price target
Is GSS a buy right now?
Trend: GSS is trading below the 50-day average (-6.25%), RSI 30 — neutral momentum, with a 3-month return of +27.12%.
Valuation & quality: Genetic Signatures Limited trades on forward P/E -1.7, price-to-book 0.48; fundamentals show net margin -72.5%, return on equity -32.6%, revenue growth -5.4% year on year.
Analyst consensus: 1 analysts have a mean 12-month price target of A$0.31 (+313.3% vs the last close; range A$0.31 – A$0.31), consensus rating “none”.
Our screen: BUY (score 2) — Commodity-linked microcap with minimal semiconductor relevance and weak investability.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -20.00% | +0.00% | -12.50% | +0.00% | -14.30% | +50.00% | -11.10% | +0.00% |
Fundamentals
Analyst price target
Technical signals
About Genetic Signatures Limited
Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.
Sector: Healthcare · Industry: Diagnostics & Research · Australia · Website
Related Semiconductors picks
Browse: all ASX stocks · Semiconductors picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.